Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Investigation of International Nonproprietary Names (INN) Nomenclature System For Biotechnological Products

생명공학의약품의 국제일반명 명명체계 조사

  • Kim, Eun-Sook (College of Pharmacy, Duksung Women's University) ;
  • Song, Jae-In (College of Pharmacy, Duksung Women's University) ;
  • Moon, A-Ree (College of Pharmacy, Duksung Women's University)
  • 김은숙 (덕성여자대학교 약학대학) ;
  • 송재인 (덕성여자대학교 약학대학) ;
  • 문애리 (덕성여자대학교 약학대학)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

An International Nonproprietary Name (INN) identifies a pharmaceutical substance or active pharmaceutical ingredient by a unique name that is globally recognized and is of public property. Also known as the generic or common names, the official INNs are provided by national and international nomenclature bodies such as United States Adopted Names (USAN), British Approved Names (BAN), Japanese Accepted Names (JAN) and World Health Organization (WHO). Due to the increasing interest on the development of biotechnological products in Korea, needs for the formulated nomenclature body in Korea are arising for systemic management of newly developed biotechnological products. This study investigated and analyzed nomenclature systems and procedures for the selection of recommended INN for biotechnological products in WHO, USAN and JAN. Based on these documents from advanced countries, we suggested a Korean INN nomenclature organization named KAN (Korean Adopted Names or Korean Agreed Names). Composition and roles of KAN and KAN expert committee and a working process for INN selection/approval were also proposed. Taken together, this study provides a detailed information on INN system recognized worldwide and suggests guidelines for establishment of INN nomenclature system for biotechnological products in Korea.

Keywords

References

  1. Boring, D. (1997). The development and adoption of nonproprietary, established, and proprietary names for pharmaceuticals. Drug Info J., 31, 621-634 https://doi.org/10.1177/009286159703100301
  2. Consultation on International Nonproprietary Names (INN) and biological products, INN Working Document00.118 (2002)
  3. Graphic representation of chemical formulae in the publications of international nonproprietary names (INN) for pharmaceutical substances, WHO/PHARM/95.579 (1997)
  4. Guidelines on the use of International Nonproprietary Names (INNs) for pharmaceutical substances, WHO/PharmS/ Nom1570 (1997)
  5. International Nonproprietary Names: revised procedure, WHO/EB115/11 (2004)
  6. International nonproprietary names (INN) for biological and biotechnological substances, INN Working Document05.179 (2006)
  7. INN nomenclature for peptides, glycopeptides, proteins and glycoproteins, WHO/PharmS/Nom1428 (1994)
  8. INNs for immunoglobulins, WHO/PharmS/Nom1517 (1995)
  9. INNs for biosynthetic vaccines, WHO/PharmS/Nom1419 (1994)
  10. INNs for recombinant vaccines and viruses, WHO/PharmS/ Nom1719 (1998)
  11. Pharmacological Action and Therapeutic Use of Drugs, list of terms, English/French/Spanish, PHARM/96.320 (1996)
  12. Pre-stems: suffixes used in the selection of INNs, INN Working Document 06.186/P (2006)
  13. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, WHO/ EDM/QSM/2004.5 (2004)
  14. WHO Drug Information, Vol 19, 2 (2005)
  15. '생명공학의약품의 국제일반명 설정에 관한 연구'(연구책임자 문애리), 식품의약품안전청 용역과제 최종보고서 (2006)
  16. 약식심사발제 0331001호 규정, 일본후생노동성 (2006)